Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Vega DM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Botella-Casas G; Maxillofacial Surgery Service, Hospital Clinico Universitario of Valencia, Valencia, Spain. gonzalobotellacasas@gmail.com., Marqués-Mateo M; Maxillofacial Surgery Service, Hospital Clinico Universitario of Valencia, Valencia, Spain., Miragall-Alba L; Maxillofacial Surgery Service, Hospital Clinico Universitario of Valencia, Valencia, Spain., Río-Vega DM; Maxillofacial Surgery Service, Hospital Clinico Universitario of Valencia, Valencia, Spain., González-Soler E; Department of Anatomy and Embryology, University of Valencia, Valencia, Spain., Puche-Torres M; Head of Service of Maxillofacial Surgery, Hospital Clinico Universitario of Valencia, INCLIVA, Valencia, Spain.
Publikováno v:
Oral and maxillofacial surgery [Oral Maxillofac Surg] 2024 Jun; Vol. 28 (2), pp. 963-966. Date of Electronic Publication: 2023 Nov 20.
Autor:
Maldonado-Barrueco A; Clinical Microbiology Department, Hospital Universitario La Paz, Madrid, Spain. alfredo.maldonado@salud.madrid.org., Gutiérrez-Arroyo A; Clinical Microbiology Department, Hospital Universitario La Paz, Madrid, Spain., Bloise I; Clinical Microbiology Department, Hospital Universitario La Paz, Madrid, Spain., de Ceano-Vivas M; Paediatric Emergency Department, Hospital Universitario La Paz, Madrid, Spain., Rivera-Nuñez A; Adults Emergency Department, Hospital Universitario La Paz, Madrid, Spain., Santos-Olmos RT; Adults Emergency Department, Hospital Universitario La Paz, Madrid, Spain., Vega DM; Clinical Microbiology Department, Hospital Universitario La Paz, Madrid, Spain., García-Rodríguez J; Clinical Microbiology Department, Hospital Universitario La Paz, Madrid, Spain.
Publikováno v:
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2024 May; Vol. 43 (5), pp. 853-861. Date of Electronic Publication: 2024 Feb 29.
Autor:
Vega DM; Friends of Cancer Research, Washington., Yee LM; National Cancer Institute, Bethesda., McShane LM; National Cancer Institute, Bethesda., Williams PM; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick., Chen L; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick., Vilimas T; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick., Fabrizio D; Foundation Medicine Inc., Cambridge., Funari V; NeoGenomics Laboratories, Aliso Viejo, USA., Newberg J; Foundation Medicine Inc., Cambridge., Bruce LK; NeoGenomics Laboratories, Aliso Viejo, USA., Chen SJ; ACT Genomics, Taipei, Taiwan., Baden J; Bristol Myers Squibb Co., Princeton., Carl Barrett J; AstraZeneca Pharmaceuticals LP, Waltham, USA., Beer P; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Butler M; LGC Clinical Diagnostics, Gaithersburg., Cheng JH; ACT Genomics, Taipei, Taiwan., Conroy J; OmniSeq Inc., Buffalo., Cyanam D; Clinical Sequencing Division, Thermo Fisher Scientific, Ann Arbor., Eyring K; Intermountain Precision Genomics, St. George., Garcia E; Brigham and Women's Hospital, Boston, USA., Green G; Bristol Myers Squibb Co., Princeton., Gregersen VR; QIAGEN Inc, Aarhus, Denmark., Hellmann MD; Memorial Sloan Kettering Cancer Center, New York., Keefer LA; Personal Genome Diagnostics, Baltimore., Lasiter L; Friends of Cancer Research, Washington., Lazar AJ; The University of Texas MD Anderson Cancer Center, Houston., Li MC; National Cancer Institute, Bethesda., MacConaill LE; Brigham and Women's Hospital, Boston, USA., Meier K; Illumina Inc, Clinical Genomics, San Diego., Mellert H; Biodesix, Inc., Boulder., Pabla S; OmniSeq Inc., Buffalo., Pallavajjalla A; Johns Hopkins University, Baltimore., Pestano G; Biodesix, Inc., Boulder., Salgado R; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Samara R; QIAGEN Inc, Aarhus, Denmark., Sokol ES; Foundation Medicine Inc., Cambridge., Stafford P; Caris Life Sciences Inc, Phoenix, Arizona, USA., Budczies J; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Tom W; Clinical Sequencing Division, Thermo Fisher Scientific, Ann Arbor., Valkenburg KC; Personal Genome Diagnostics, Baltimore., Wang XZ; EMD Serono Research and Development Institute, Inc., Billerica., Weigman V; Q Squared Solutions, Durham., Xie M; AstraZeneca Pharmaceuticals LP, Waltham, USA., Xie Q; General Dynamics Information Technology, Inc., Columbia, USA., Zehir A; Memorial Sloan Kettering Cancer Center, New York., Zhao C; Illumina Inc, Clinical Genomics, San Diego., Zhao Y; National Cancer Institute, Bethesda., Stewart MD; Friends of Cancer Research, Washington. Electronic address: mstewart@focr.org., Allen J; Friends of Cancer Research, Washington.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Jan; Vol. 35 (1), pp. 145. Date of Electronic Publication: 2023 Aug 08.
Autor:
LeBlanc TW; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, USA., Russell NH; Department of Haematology, Guy's Hospital, London, UK., Hernandez-Aldama L; ArmorUp for LIFE, Philadelphia, USA., Panter C; Adelphi Values Patient-Centered Outcomes, Cheshire, UK. charlotte.panter@adelphivalues.com., Bell TJ; Pfizer Inc., New York, USA., Welch V; Pfizer Inc., New York, USA., Vega DM; Friends of Cancer Research, Washington, DC, USA., O'Hara L; Adelphi Values Patient-Centered Outcomes, Cheshire, UK., Stein J; Adelphi Values Patient-Centered Outcomes, Cheshire, UK., Barclay M; Adelphi Values Patient-Centered Outcomes, Cheshire, UK., Peloquin F; Pfizer Canada ULC, Kirkland, Canada., Brown A; Pfizer Ltd, Tadworth, UK., Healy J; Pfizer Canada ULC, Kirkland, Canada., Morgan L; Adelphi Values Patient-Centered Outcomes, Cheshire, UK., Gater A; Adelphi Values Patient-Centered Outcomes, Cheshire, UK., Hohman R; Friends of Cancer Research, Washington, DC, USA., Amer K; Pfizer Ltd, Tadworth, UK., Maze D; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Walter RB; Fred Hutchinson Cancer Research Center, Seattle, USA.
Publikováno v:
Oncology and therapy [Oncol Ther] 2022 Dec; Vol. 10 (2), pp. 421-440. Date of Electronic Publication: 2022 Jun 13.
Autor:
Vega DM; Friends of Cancer Research, Washington, DC., Nishimura KK; Cancer Research And Biostatistics (CRAB), Seattle, WA., Zariffa N; NMD Group LLC, Bala Cynwyd, PA., Thompson JC; Division of Pulmonary, Allergy and Critical Care Medicine, Thoracic Oncology Group, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Hoering A; Cancer Research And Biostatistics (CRAB), Seattle, WA., Cilento V; Cancer Research And Biostatistics (CRAB), Seattle, WA., Rosenthal A; Cancer Research And Biostatistics (CRAB), Seattle, WA., Anagnostou V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Baden J; Translational Medicine, Bristol Myers Squibb, Princeton, NJ., Beaver JA; Oncology Center of Excellence, Food and Drug Administration (FDA), Silver Spring, MD., Chaudhuri AA; Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO.; Department of Genetics, Washington University School of Medicine, St Louis, MO.; Department of Computer Science and Engineering, Washington University, St Louis, MO.; Siteman Cancer Center, Washington University School of Medicine, St Louis, MO., Chudova D; Guardant Health Inc, Redwood City, CA., Fine AD; Research and Development, Foundation Medicine Inc, Cambridge, MA., Fiore J; Oncology Development, Bristol Myers Squibb, Princeton, NJ., Hodge R; Late Oncology Statistics, Oncology Biometrics, AstraZeneca, Cambridge, United Kingdom., Hodgson D; Translational Medicine, Oncology Research & Development, AstraZeneca, Waltham, MA., Hunkapiller N; GRAIL, Menlo Park, CA.; During the conduct of this work and development of the manuscript, N.H. was affiliated with GRAIL, Inc; however, is not affiliated with GRAIL, Inc at the time of submission., Klass DM; Assay Development, Roche Sequencing Solutions, Pleasanton, CA., Kobie J; Translational Oncology, Early Oncology Statistics, Merck Research Laboratories, Kenilworth, NJ., Peña C; Companion Diagnostics, Oncology Early Development, Merck Research Laboratories, Kenilworth, NJ., Pennello G; Division of Imaging, Diagnostics, and Software Reliability, Office of Science and Engineering Laboratories, Food and Drug Administration (FDA), Silver Spring, MD., Peterman N; Foundation Medicine Inc, San Diego, CA., Philip R; Division of Molecular Genetics, Office of Health Technology 7 (In Vitro Diagnostics and Radiological Health), Food and Drug Administration (FDA), Silver Spring, MD., Quinn KJ; Guardant Health Inc, Redwood City, CA., Raben D; Product Development Oncology, Genentech Inc, South San Francisco, CA., Rosner GL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Sausen M; Translational Medicine, Bristol Myers Squibb, Princeton, NJ., Tezcan A; Foundation Medicine Inc, San Diego, CA., Xia Q; Product Development Data Sciences, Genentech Inc, South San Francisco, CA., Yi J; Product Development Oncology, Genentech Inc, South San Francisco, CA., Young AG; Research and Development, Foundation Medicine Inc, Cambridge, MA., Stewart MD; Friends of Cancer Research, Washington, DC., Carpenter EL; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Aggarwal C; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Allen J; Friends of Cancer Research, Washington, DC.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2022 Aug; Vol. 6, pp. e2100372.
Autor:
Bustamante J; Department of Pediatrics and Infectious Diseases, Hospital Universitario Doctor José Molina Orosa, Las Palmas, Spain; La Paz Research Institute (IdiPAZ) Madrid, Spain; Universidad Autónoma de Madrid (UAM), Spain; General Pediatrics and Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain., Sainz T; La Paz Research Institute (IdiPAZ) Madrid, Spain; Universidad Autónoma de Madrid (UAM), Spain; General Pediatrics and Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain; Red de Investigación Traslacional en Infectología Pediátrica (RITIP), Spain; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Spain. Electronic address: talia.sainz@salud.madrid.org., Ara-Montojo MF; La Paz Research Institute (IdiPAZ) Madrid, Spain; General Pediatrics and Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain; General Pediatrics Department, Hospital de Quiron, Pozuelo, Spain., Almirón MD; La Paz Research Institute (IdiPAZ) Madrid, Spain; Biostatistics Department, La Paz University Hospital, Spain., Subirats M; La Paz Research Institute (IdiPAZ) Madrid, Spain; Department of Microbiology and Parasitology, Hospital La Paz Madrid, Spain., Vega DM; La Paz Research Institute (IdiPAZ) Madrid, Spain; Department of Microbiology and Parasitology, Hospital La Paz Madrid, Spain., Mellado MJ; La Paz Research Institute (IdiPAZ) Madrid, Spain; Universidad Autónoma de Madrid (UAM), Spain; General Pediatrics and Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain; Red de Investigación Traslacional en Infectología Pediátrica (RITIP), Spain; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Spain., López-Hortelano MG; La Paz Research Institute (IdiPAZ) Madrid, Spain; General Pediatrics and Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain; Red de Investigación Traslacional en Infectología Pediátrica (RITIP), Spain; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Spain.
Publikováno v:
Travel medicine and infectious disease [Travel Med Infect Dis] 2022 May-Jun; Vol. 47, pp. 102287. Date of Electronic Publication: 2022 Mar 15.
Autor:
Vega DM; Friends of Cancer Research, Washington, USA., Yee LM; National Cancer Institute, Bethesda, USA., McShane LM; National Cancer Institute, Bethesda, USA., Williams PM; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick, USA., Chen L; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick, USA., Vilimas T; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick, USA., Fabrizio D; Foundation Medicine Inc., Cambridge, USA., Funari V; NeoGenomics Laboratories, Aliso Viejo, USA., Newberg J; Foundation Medicine Inc., Cambridge, USA., Bruce LK; NeoGenomics Laboratories, Aliso Viejo, USA., Chen SJ; ACT Genomics, Taipei, Taiwan., Baden J; Bristol Myers Squibb Co., Princeton, USA., Carl Barrett J; AstraZeneca Pharmaceuticals LP, Waltham, USA., Beer P; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Butler M; LGC Clinical Diagnostics, Gaithersburg, USA., Cheng JH; ACT Genomics, Taipei, Taiwan., Conroy J; OmniSeq Inc., Buffalo, USA., Cyanam D; Clinical Sequencing Division, Thermo Fisher Scientific, Ann Arbor, USA., Eyring K; Intermountain Precision Genomics, St. George, USA., Garcia E; Brigham and Women's Hospital, Boston, USA., Green G; Bristol Myers Squibb Co., Princeton, USA., Gregersen VR; QIAGEN Inc, Aarhus, Denmark., Hellmann MD; Memorial Sloan Kettering Cancer Center, New York, USA., Keefer LA; Personal Genome Diagnostics, Baltimore, USA., Lasiter L; Friends of Cancer Research, Washington, USA., Lazar AJ; The University of Texas MD Anderson Cancer Center, Houston, USA., Li MC; National Cancer Institute, Bethesda, USA., MacConaill LE; Brigham and Women's Hospital, Boston, USA., Meier K; Illumina Inc, Clinical Genomics, San Diego, USA., Mellert H; Biodesix, Inc., Boulder, USA., Pabla S; OmniSeq Inc., Buffalo, USA., Pallavajjalla A; Johns Hopkins University, Baltimore, USA., Pestano G; Biodesix, Inc., Boulder, USA., Salgado R; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Samara R; QIAGEN Inc, Aarhus, Denmark., Sokol ES; Foundation Medicine Inc., Cambridge, USA., Stafford P; Caris Life Sciences Inc, Phoenix, USA., Budczies J; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Tom W; Clinical Sequencing Division, Thermo Fisher Scientific, Ann Arbor, USA., Valkenburg KC; Personal Genome Diagnostics, Baltimore, USA., Wang XZ; EMD Serono Research and Development Institute, Inc., Billerica, USA., Weigman V; Q Squared Solutions, Durham, USA., Xie M; AstraZeneca Pharmaceuticals LP, Waltham, USA., Xie Q; General Dynamics Information Technology, Inc., Columbia, USA., Zehir A; Memorial Sloan Kettering Cancer Center, New York, USA., Zhao C; Illumina Inc, Clinical Genomics, San Diego, USA., Zhao Y; National Cancer Institute, Bethesda, USA., Stewart MD; Friends of Cancer Research, Washington, USA. Electronic address: mstewart@focr.org., Allen J; Friends of Cancer Research, Washington, USA.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Dec; Vol. 32 (12), pp. 1626-1636. Date of Electronic Publication: 2021 Oct 01.